Signatures of T cells as correlates of immunity to Francisella tularensis. 2012

Kjell Eneslätt, and Monica Normark, and Rafael Björk, and Cecilia Rietz, and Carl Zingmark, and Lawrence A Wolfraim, and Svenja Stöven, and Anders Sjöstedt
Laboratory for Molecular Infection Medicine Sweden (MIMS), Department of Clinical Microbiology, Clinical Bacteriology, Umeå University, Umeå, Sweden.

Tularemia or vaccination with the live vaccine strain (LVS) of Francisella tularensis confers long-lived cell-mediated immunity. We hypothesized that this immunity depends on polyfunctional memory T cells, i.e., CD4(+) and/or CD8(+) T cells with the capability to simultaneously express several functional markers. Multiparametric flow cytometry, measurement of secreted cytokines, and analysis of lymphocyte proliferation were used to characterize in vitro recall responses of peripheral blood mononuclear cells (PBMC) to killed F. tularensis antigens from the LVS or Schu S4 strains. PBMC responses were compared between individuals who had contracted tularemia, had been vaccinated, or had not been exposed to F. tularensis (naïve). Significant differences were detected between either of the immune donor groups and naïve individuals for secreted levels of IL-5, IL-6, IL-10, IL-12, IL-13, IFN-γ, MCP-1, and MIP-1β. Expression of IFN-γ, MIP-1β, and CD107a by CD4(+)CD45RO(+) or CD8(+)CD45RO(+) T cells correlated to antigen concentrations. In particular, IFN-γ and MIP-1β strongly discriminated between immune and naïve individuals. Only one cytokine, IL-6, discriminated between the two groups of immune individuals. Notably, IL-2- or TNF-α-secretion was low. Our results identify functional signatures of T cells that may serve as correlates of immunity and protection against F. tularensis.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005604 Francisella tularensis The etiologic agent of TULAREMIA in man and other warm-blooded animals. Bacterium tularense,Brucella tularensis,Francisella tularense,Pasteurella tularensis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Kjell Eneslätt, and Monica Normark, and Rafael Björk, and Cecilia Rietz, and Carl Zingmark, and Lawrence A Wolfraim, and Svenja Stöven, and Anders Sjöstedt
January 1989, Reviews of infectious diseases,
Kjell Eneslätt, and Monica Normark, and Rafael Björk, and Cecilia Rietz, and Carl Zingmark, and Lawrence A Wolfraim, and Svenja Stöven, and Anders Sjöstedt
March 1993, Infection and immunity,
Kjell Eneslätt, and Monica Normark, and Rafael Björk, and Cecilia Rietz, and Carl Zingmark, and Lawrence A Wolfraim, and Svenja Stöven, and Anders Sjöstedt
March 2022, Journal of immunology (Baltimore, Md. : 1950),
Kjell Eneslätt, and Monica Normark, and Rafael Björk, and Cecilia Rietz, and Carl Zingmark, and Lawrence A Wolfraim, and Svenja Stöven, and Anders Sjöstedt
January 1991, Clinical and experimental immunology,
Kjell Eneslätt, and Monica Normark, and Rafael Björk, and Cecilia Rietz, and Carl Zingmark, and Lawrence A Wolfraim, and Svenja Stöven, and Anders Sjöstedt
November 1992, Infection and immunity,
Kjell Eneslätt, and Monica Normark, and Rafael Björk, and Cecilia Rietz, and Carl Zingmark, and Lawrence A Wolfraim, and Svenja Stöven, and Anders Sjöstedt
April 2014, Infection and immunity,
Kjell Eneslätt, and Monica Normark, and Rafael Björk, and Cecilia Rietz, and Carl Zingmark, and Lawrence A Wolfraim, and Svenja Stöven, and Anders Sjöstedt
January 1982, Scandinavian journal of infectious diseases,
Kjell Eneslätt, and Monica Normark, and Rafael Björk, and Cecilia Rietz, and Carl Zingmark, and Lawrence A Wolfraim, and Svenja Stöven, and Anders Sjöstedt
January 2018, Frontiers in cellular and infection microbiology,
Kjell Eneslätt, and Monica Normark, and Rafael Björk, and Cecilia Rietz, and Carl Zingmark, and Lawrence A Wolfraim, and Svenja Stöven, and Anders Sjöstedt
December 1985, Journal of clinical microbiology,
Kjell Eneslätt, and Monica Normark, and Rafael Björk, and Cecilia Rietz, and Carl Zingmark, and Lawrence A Wolfraim, and Svenja Stöven, and Anders Sjöstedt
September 1985, Infection control : IC,
Copied contents to your clipboard!